Advanced search
Publication Cover
OncoTargets and Therapy Volume 15, 2022 - Issue
Submit an article Journal homepage
275
Views
3
CrossRef citations to date
0
Altmetric
Original Research

TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer

Xiaoyue Liu1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-8516-903XView further author information
ORCID Icon,
Tianhao Zhou3 State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Yongmei Wang1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Min Pei1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Guifeng Wang1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Wendi Chu1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7053-4102View further author information
ORCID Icon,
Qi Wang1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Shaoqian Du3 State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Hongxia Wang3 State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Chunhe Wang1 Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China;2 University of Chinese Academy of Sciences, Beijing, People’s Republic of China;4 Research and Development Center, Dartsbio Pharmaceuticals, Zhongshan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 509-520 | Published online: 03 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.